Back to search

Ireland· IE-PA-EU/1/12/798/005-006

Ibandronic acid Accord 3 mg solution for injection in pre-filled syringe

A ibandronic acid product containing ibandronic acid + ibandronate sodium monohydrate + ibandronate sodium, registered in Ireland by Accord Healthcare S.L.U.. The same ATC class is registered in 16 of our 19 countries.

ATC M05BA06

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedIbandronic acid Accord 3 mg solution …ATCM05BA06REGISTER NO.IE-PA-EU/1/12/798/005…PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Ibandronic acid is registered in 16 of 19 countries.

Countries holding a registration under ATC M05BA06 (ibandronic acid), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 10 of them publish a price we can compare per daily dose

Ibandronic acid · ATC M05BA06

16 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ibandronic acid costs, country by country.

Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.089 in United States to $1.30 in Switzerland — a ×15 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Ibandronic acid · price per daily dose (5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.30
  • ES Spain$0.49
  • IT Italy$0.38
  • US United States$0.089 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

HPRA (Ireland)
Active substance
Ibandronic acid + Ibandronate sodium monohydrate + Ibandronate sodium
Manufacturer
Accord Healthcare S.L.U.
Country
Ireland (IE)
ATC code
M05BA06
ATC class
Ibandronic acid
Defined daily dose
5 mg, O
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/12/798/005-006

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

228 interactions on record for ibandronic acid.

Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ibandronic acid · interactions on record

228 records

  • 12 severe
  • 98 moderate
  • 94 info

Most severe, free to view

  • EtelcalcetideH05BX04severe
  • SirolimusL01EG04severe
  • SirolimusL04AA10severe
  • TacrolimusL04AD02severe

24 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/aad02cd5-24c5-48b0-8876-4868d264360d
GET /v1/drugs/aad02cd5-24c5-48b0-8876-4868d264360d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection in pre-filled syringe",
  "routes": [
    "Intravenous use"
  ],
  "source": "hpra",
  "atc_all": [
    "M05BA",
    "M05BA06"
  ],
  "strength": null,
  "pa_number": "EU/1/12/798/005-006",
  "substances": [
    "Ibandronic acid",
    "Ibandronate sodium monohydrate",
    "Ibandronate sodium"
  ],
  "legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": null,
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about ibandronic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.